Ventral Hernia Clinical Trial
— UNITEOfficial title:
A Multicenter Belgian Trial on Ventral Hernia Repair. UNITE Study Protocol Number: RB-UNITE-01
Verified date | August 2023 |
Source | University Hospital, Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients with incisional midline ventral hernias with a minimal width of 3 cm and a maximal width of 8 cm, treated according to the standard practice of the participating investigators. Patients can be treated with the following ventral hernia repair approaches: - Laparoscopic ventral hernia repair with closure of the defect (IPOM+) - Open ventral hernia repair with closure of the defect (retromuscular repair) - Robotic ventral hernia repair with closure of the defect (retromuscular repair) To evaluate the total number of days spent in the hospital within a period of 90 days post-operative. This will be calculated by adding the hospital length of stay for initial surgery or index-procedure, length of stay for any additional readmission resulting from the surgery or re-interventions, and emergency room visits resulting from the surgery or Serious Adverse Event (SAE) related to the index-procedure. Secondary objectives: To assess the safety, performance and efficacy of laparoscopic, open and robotic ventral hernia repair.
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | April 30, 2024 |
Est. primary completion date | July 31, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Patient with incisional midline ventral hernia (M2: epigastric, M3: umbilical, M4: infra-umbilical) with a minimal width of 3 cm and a maximum width of 8 cm. Multiple hernia defects (Swiss cheese) are allowed according to European Hernia Society (EHS) classification (Appendix 1). 2. Recurrences are only allowed to be included after former primary repair (suture repair without mesh). 3. Patients with ASA grade I to III. 4. Patient is at least 18 years old. 5. Patient must sign and date the informed consent form prior to treatment. 6. Patient is able to tolerate general anesthesia. Exclusion Criteria: 1. Patient with a life expectancy of less than 2 years. 2. Patient is suspected of being unable to comply with the study protocol. 3. Patient is pregnant. 4. Patient needs acute surgery. 5. Patient is enrolled in another study. |
Country | Name | City | State |
---|---|---|---|
Belgium | Ghent University Hospital | Ghent | East Flanders |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Ghent | Archer Research, Royal Belgian Society for Surgery |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total number of days in the hospital | This will be calculated by adding the hospital length of stay for initial surgery, length of stay for any additional readmission resulting from the surgery, and emergency room visits resulting from the surgery. This information will be collected up to 90 days after the surgery. The hospital length of stay for the initial surgery will be assessed using a Modified Post Anaesthetic Discharge Scoring System (PADSS) | 90 days post-operative | |
Secondary | Intra-operative adverse events | Definitions according to ICH-GCP E6 (R2) | index procedure, 30 days post-operative, and 90 days post-operative | |
Secondary | Number of participants with Surgical Site Infection (SSI) | CDC definition | post-operative at 30 days, 1 year, and 2 years | |
Secondary | Number of participants with Surgical Site Occurence (SSO) | Hematoma, seroma, dehiscence, necrosis, non-healing wound found on abdominal exam | post-operative at 30 days, 1 year, and 2 years | |
Secondary | Operating time | Total operating time from incision to last stitch (in minutes) | index procedure | |
Secondary | Effective day of discharge | Number of effective hospital stay after the index procedure | index procedure, and post-operative at 30 days | |
Secondary | Conversion rate | Conversion rate for the laparoscopic and robot-assisted groups | index procedure | |
Secondary | Preoperative and post-operative pain | Pain scoring using the Visual Analog Scale (VAS) The VAS scoring system is frequently used as a reliable and valid measure of pain. It contains a 0 - 100 grading scale with 0 equaling no pain and 100 equaling the worst conceivable pain. The patient is asked to select the number on the scale that corresponds to the worst level of pain he / she experiences in rest and activity. The patient will be asked to bend over to score pain during activity. Pain is classified into mild (1 - 30 mm), moderate (31 - 60 mm) and severe (61 - 100 mm). Absence of pain is defined as VAS = 0. | enrollment, post-operative at 30 days, 1 year, and 2 years | |
Secondary | Analgesic intake | Amount and type of analgesic intake | post-operative at 30 days, 1 year, and 2 years | |
Secondary | Quality of life improvement: Carolina's Comfort Scale (CCS) | Carolina's Comfort Scale (CCS) | enrollment, post-operative at 30 days, 1 year, and 2 years | |
Secondary | Body image | Body Image Questionnaire (BIQ) The BIQ is a ten-item questionnaire incorporating body image and cosmetic subscales. The body image scale measures patients' perception and satisfaction with their bodies after surgery, and it is calculated by reverse scoring and summing the responses to questions 1 through 5. It ranges from 5 to 20 with a higher number representing greater body image perception. The cosmetic scale assesses satisfaction with surgical scars and is calculated by simply summing responses to questions 6 through 8, for a score range of 3 to 24, with a higher score indicating greater cosmetic satisfaction. The last two items (9, 10) score self-confidence before and after surgery. | enrollment, post-operative at 30 days, 1 year, and 2 years | |
Secondary | Recurrence | Recurrent hernia | post-operative at 30 days, 1 year, and 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06016426 -
Mass Closure vs Layer by Layer Closure
|
N/A | |
Recruiting |
NCT05572021 -
A Comparison of the Outcomes in Fortiva and Strattice Mesh
|
N/A | |
Completed |
NCT02263599 -
Conservative Treatment For Ventral Hernia
|
||
Completed |
NCT02263625 -
Regional Differences In Indication for Ventral Hernia Repair
|
||
Completed |
NCT02292264 -
Risk Factors and Complications of Ventral Hernia Repair
|
||
Completed |
NCT01961687 -
A Prospective, Multi-Center Study of Phasix™ Mesh for Ventral or Incisional Hernia Repair.
|
N/A | |
Completed |
NCT01325246 -
Reoperation Rate Versus Clinical Recurrence After Ventral Hernia Repair
|
N/A | |
Completed |
NCT03283982 -
Laparoscopic vs. Robotic Ventral Hernia Repair With IPOM
|
N/A | |
Not yet recruiting |
NCT05526209 -
Longitudinal Relaxing Incision as a Technique for Recurrence Prevention in Ventral Hernia
|
||
Completed |
NCT04438369 -
Evaluation of Ultrasound-guided Erector Spinae Block for Postoperative Analgesia in Laprascopic Ventral Hernia Repair.
|
N/A | |
Recruiting |
NCT04173884 -
Video-based Collaborative Learning to Improve Ventral Hernia Repair
|
N/A | |
Recruiting |
NCT02703662 -
Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction
|
Phase 2/Phase 3 | |
Completed |
NCT03938688 -
Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation
|
N/A | |
Completed |
NCT01719718 -
The Influence of Closing the Gap on Postoperative Seroma and Recurrences in Laparoscopic Ventral Hernia Repair
|
N/A | |
Completed |
NCT03342040 -
Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair
|
N/A | |
Completed |
NCT04150796 -
Comparing eTEP and Laparoscopic Intraperitoneal Onlay Mesh (IPOM) for Ventral Hernias
|
N/A | |
Recruiting |
NCT03222102 -
Ventral Hernia Prevention After Liver Transplantation
|
N/A | |
Completed |
NCT05610267 -
Gentrix® Surgical Matrix for Soft Tissue Reinforcement in Ventral Hernia Repair
|
||
Terminated |
NCT01794338 -
The Use of Biologic Mesh vs Bioabsorbable Mesh During Ventral Hernia Repair in At-risk Patients
|
N/A | |
Completed |
NCT01886963 -
A Clinical Trial Using Spy Elite System in Planning Tissue Advancement Flaps After Ventral Hernia Repair
|
N/A |